ITC for Advanced Molecular Diagnostics

chang hong

Hong Chang

Senior Research Scientist

In July, Dr. Hong Chang joined OSCAR as a Senior Research Scientist in OSCAR-Prenetics Innovation and Technology Centre for Advanced Diagnostics.

Before joining OSCAR, Dr. Chang was Chief Technology Officer and QA/RA manager at MEStar (Oxford spin-out technology company) and is experienced in obtaining CE/MHRA, ISO13485 application approval and maintaining QMS system. She was heavily involved in development of the rapid test kit for COVID-19 created by Prof. Zhanfeng Cui, Prof. Wei Huang and their teams. She participated in early lab-based research at Oxford’s IBME and was instrumental in demonstrating compliance and seeking regulatory approval. her contribution helped the test kit, Oxsed RaVid Direct, gain its CE mark in early July 2020.

Dr. Chang completed her doctoral degrees in Materials Science at Queen Mary University of London. She undertook a postdoctoral position in The Institute of Biomedical Engineering (IMBE) at the University of Oxford. Her research there involved fabrication of corsslinked protein membranes in microfluidics channel  for use as 3D cell culture.

After completing her postdoctoral research at Oxford, Dr. Chang started developing her career in industry area, specialist in In-vitro diagnostic medical devices. She has been involved in  biomedical product design and development at all stages.


li lin

Dr. Lin Li

Research Scientist

Dr. Lin Li joined OSCAR in October 2022 as a Research Scientist of OSCAR Innovation Technology Center for Advanced Molecular Diagnostics. She received her PhD from the Academy of Medical Sciences in 2017 and conducted post-doctoral work at the Suzhou Institute of Nanotechnology and Nano-Bionics, Chinese Academy of Sciences from 2017 to 2022. Her research interests include the development of tumor marker identification and detection technology, targeting membrane molecules immunotherapy, and the development and application of protein engineering technology.

After joining OSCAR, Dr. Li will focus on the development of molecular diagnostic reagents to provide faster, more sensitive, and more specific technologies for applications in infectious diseases, blood screening, and early detection of tumors.




wei xin tu pian

Binbin Li

Research Assistant

Binbin Li, Research Assistant, joined OSCAR in September 2018. She graduated from the Department of Clinical Veterinary Medicine of Huazhong Agricultural University in 2014 with a graduate degree. Prior to joining OSCAR, she worked at Pfizer (Wuhan) R&D Center as a global safety data management specialist. At OSCAR, her research interests focus on the development and application of molecular diagnostic technologies for animal infectious diseases and early cancer screening.